Welcome to LookChem.com Sign In|Join Free
  • or
C12H10ClFN2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1620488-80-3

Post Buying Request

1620488-80-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1620488-80-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1620488-80-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,0,4,8 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1620488-80:
(9*1)+(8*6)+(7*2)+(6*0)+(5*4)+(4*8)+(3*8)+(2*8)+(1*0)=163
163 % 10 = 3
So 1620488-80-3 is a valid CAS Registry Number.

1620488-80-3Relevant academic research and scientific papers

In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51

De Vita, Daniela,Moraca, Francesca,Zamperini, Claudio,Pandolfi, Fabiana,Di Santo, Roberto,Matheeussen, An,Maes, Louis,Tortorella, Silvano,Scipione, Luigi

, p. 28 - 33 (2016/03/01)

Sterol 14α-demethylase (CYP51) is a key enzyme involved in the survival and virulence of many parasite protozoa, such as Trypanosoma and Leishmania species, thus representing a valuable drug target for the treatment of Kinetoplastid diseases. A set of azole-based compounds selected from an in-house compound library was in vitro screened against different human protozoan parasites. Several compounds showed selective activity against Trypanosoma cruzi, with compound 7 being the most active (IC50 = 40 nM). Given the structural similarity between the compounds here reported and known CYP51 inhibitors, a molecular docking study was performed to assess their binding with protozoal target and to rationalize the biological activity data.

Synthesis, biological evaluation and structure-activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors

Moraca, Francesca,De Vita, Daniela,Pandolfi, Fabiana,Di Santo, Roberto,Costi, Roberta,Cirilli, Roberto,D'Auria, Felicia Diodata,Panella, Simona,Palamara, Anna Teresa,Simonetti, Giovanna,Botta, Maurizio,Scipione, Luigi

, p. 665 - 673 (2014/07/22)

A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against Candida albicans, non-albicans Candida species, Cryptococcus neoformans and dermathophytes. Because of their racemic nature, the most active compounds 5f and 6c were tested as pure enantiomers. For 6c the (R)-enantiomer resulted more active than the (S)-one, otherwise for 5f the (S)-enantiomer resulted the most active. To rationalize the experimental data, a ligand-based computational study was carried out; the results of the modelling study show that (S)-5f and (R)-6c perfectly align to the ligand-based model, showing the same relative configuration. Preliminary studies on the human lung adenocarcinoma epithelial cells (A549) have shown that 6c, 5e and 5f possess a low cytotoxicity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1620488-80-3